Tu1954 Capsule Endoscopy Findings and Fecal Calprotectin Levels Predict Clinical Relapse in Patients With Quiescent Small Bowel Crohn's Disease

2016 ◽  
Vol 150 (4) ◽  
pp. S989
Author(s):  
Shomron Ben-Horin ◽  
Uri Kopylov ◽  
Adi Lahat ◽  
Doron Yablecovitch ◽  
Sandra Neuman ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Small Bowel ◽  
Crohn's Disease ◽  
Capsule Endoscopy ◽  
Fecal Calprotectin ◽  
Clinical Relapse

Fecal calprotectin for the prediction of small-bowel Crohn’s disease by capsule endoscopy

2016 ◽  
Vol 28 (10) ◽  
pp. 1137-1144 ◽  
Author(s):  
Uri Kopylov ◽  
Diana E. Yung ◽  
Tal Engel ◽  
Tomer Avni ◽  
Robert Battat ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Small Bowel ◽  
Crohn's Disease ◽  
Capsule Endoscopy ◽  
Fecal Calprotectin

Fecal Calprotectin as a Selection Tool for Small Bowel Capsule Endoscopy in Suspected Crohn’s Disease

2018 ◽  
Vol 24 (9) ◽  
pp. 2033-2038 ◽  
Author(s):  
Sara Monteiro ◽  
Mara Barbosa ◽  
Tiago Cúrdia Gonçalves ◽  
Pedro Boal Carvalho ◽  
Maria João Moreira ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Small Bowel ◽  
Crohn's Disease ◽  
Capsule Endoscopy ◽  
Fecal Calprotectin ◽  
Selection Tool

Su1402 SMALL BOWEL CROHN’S DISEASE AND FECAL CALPROTECTIN: RELATIONSHIP WITH SMALL BOWEL CAPSULE ENDOSCOPY AND MAGNETIC RESONANCE ENTEROGRAPHY

2019 ◽  
Vol 89 (6) ◽  
pp. AB366
Author(s):  
Cristina Romero Mascarell ◽  
Maria Carme Masamunt ◽  
Cristina Rodríguez de Miguel ◽  
Gloria Fernández-Esparrach ◽  
Sonia Rodriguez ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Magnetic Resonance ◽  
Small Bowel ◽  
Crohn's Disease ◽  
Capsule Endoscopy ◽  
Fecal Calprotectin ◽  
Magnetic Resonance Enterography

Su1221 Fecal Calprotectin Correlates With Small Bowel Inflammatory Activity Detected by Capsule Endoscopy in Patients With Established Crohn's Disease

2016 ◽  
Vol 83 (5) ◽  
pp. AB317
Author(s):  
Mara Barbosa ◽  
Sara Monteiro ◽  
Tiago Cúrdia Gonçalves ◽  
Maria João Moreira ◽  
Bruno Rosa ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Small Bowel ◽  
Crohn's Disease ◽  
Capsule Endoscopy ◽  
Fecal Calprotectin ◽  
Inflammatory Activity

Fecal calprotectin and S100A12 have low utility in prediction of small bowel Crohn's disease detected by wireless capsule endoscopy

2012 ◽  
Vol 47 (7) ◽  
pp. 778-784 ◽  
Author(s):  
Taina Sipponen ◽  
Johanna Haapamäki ◽  
Erkki Savilahti ◽  
Henrik Alfthan ◽  
Esa Hämäläinen ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Small Bowel ◽  
Crohn's Disease ◽  
Capsule Endoscopy ◽  
Fecal Calprotectin ◽  
Wireless Capsule Endoscopy ◽  
Wireless Capsule

scholarly journals Lewis Score on Capsule Endoscopy as a Predictor of the Risk for Crohn’s Disease-Related Emergency Hospitalization and Clinical Relapse in Patients with Small Bowel Crohn’s Disease

2019 ◽  
Vol 2019 ◽  
pp. 1-8 ◽  
Author(s):  
Takahiro Nishikawa ◽  
Masanao Nakamura ◽  
Takeshi Yamamura ◽  
Keiko Maeda ◽  
Tsunaki Sawada ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Small Bowel ◽  
Crohn's Disease ◽  
Capsule Endoscopy ◽  
Treatment Strategies ◽  
Inflammatory Activity ◽  
Clinical Relapse ◽  
Cutoff Value ◽  
Emergency Hospitalization ◽  
Free Rate

Background. Small bowel capsule endoscopy (CE) is a useful tool for evaluating the mucosal changes in patients with Crohn’s disease (CD). The Lewis score (LS) on CE could be used to objectively assess the inflammatory activity of the small bowel mucosa. However, only few reports on the correlation between the LS and CD prognosis exist. This study is aimed at evaluating the clinical significance of the LS by determining the cutoff value of the LS that could predict CD-related emergency hospitalization. Methods. This retrospective single-center study included 125 patients who underwent CE for small bowel CD. Eighty-six patients whose treatment was not changed after CE were analyzed. Inflammatory activity was assessed with the LS. We examined the clinical course of the patients who could be observed for 1 year after CE and investigated the LS cutoff value that could predict CD-related emergency hospitalization within 1 year. We also examined the hospitalization-free and clinical relapse-free rates using the LS cutoff value and evaluated the factors related to emergency hospitalization. Results. The LS cutoff value that could predict CD-related emergency hospitalization within 1 year was 264 (area under the curve, 0.92 (P<0.001); sensitivity, 0.80; and specificity, 0.94). The cumulative hospitalization-free rate and cumulative clinical relapse-free rate were significantly higher in patients with a LS<264 (P<0.001). Multivariate analysis showed that a LS<264 was a statistically significant factor (P=0.001; 95% CI, 0.010–0.308). Conclusion. A LS of 264 is a useful cutoff value that could predict CD-related emergency hospitalization. This LS cutoff value may help determine treatment strategies for CD.

Sign in / Sign up

Export Citation Format

Share Document